paraquat has been researched along with 1-(5-isoquinolinesulfonyl)-2-methylpiperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabie, V; Robertson, JB; Scemama, JL; Seidel, ER | 1 |
| Li, Q; Liu, W; Liu, Z; Zhang, L; Zhao, M | 1 |
2 other study(ies) available for paraquat and 1-(5-isoquinolinesulfonyl)-2-methylpiperazine
| Article | Year |
|---|---|
Paraquat uptake in the cultured gastrointestinal epithelial cell line, IEC-6.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Binding, Competitive; Calmodulin; Cell Count; Cell Line; Intestinal Mucosa; Isoquinolines; Paraquat; Piperazines; Putrescine; Rats; Spermidine; Sulfonamides | 1993 |
Protective Effects of a Rho Kinase Inhibitor on Paraquat-Induced Acute Lung Injuries in Rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute Lung Injury; Animals; Apoptosis; Endothelium, Vascular; Inflammation; Oxidative Stress; Paraquat; Permeability; Protective Agents; Protein Kinase Inhibitors; Rats; Rats, Wistar; rho-Associated Kinases | 2018 |